QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 23, Issue 5, 2002, Pages 303-307

  Kyrmizakis, Dionysios E ^a   Chimona, Theognosia S ^a   Kanoupakis, Emmanuel M ^a   Papadakis, Chariton E ^a   Velegrakis, George A ^a   Helidonis, Emmanuel S ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZITHROMYCIN; CETIRIZINE; CIPROFLOXACIN; CISAPRIDE; CLARITHROMYCIN; COTRIMOXAZOLE; EBASTINE; ERYTHROMYCIN; FEXOFENADINE; GATIFLOXACIN; GREPAFLOXACIN; ITRACONAZOLE; KETOCONAZOLE; KETOLIDE; LEVOFLOXACIN; LORATADINE; MACROLIDE; MIZOLASTINE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TERFENADINE; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

ADULT; ARTICLE; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPOKALEMIA; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM; SYNCOPE; TONSILLITIS; TORSADE DES POINTES;

EID: 0036738238     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajot.2002.124543     Document Type: Article

References (15)

1. Garson A Jr: How to measure the QT interval-What is normal? Am J Cardiol 72:14B-16B, 1993
2. Roden DM, Lazzara R, Rosen M, et al: Multiple mechanisms in the long QT syndrome. Current knowledge, gaps, and future directions. Circulation 94:1996-2012, 1996
3. Viskin S: Long QT syndromes and torsade de pointes. Lancet 354:1625-1633, 1999
4. Owens RC Jr: Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes. Pharmacotherapy 21:301-319, 2001
5. Yamada T, Fujieda S, Mori S, et al: Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 14:143-148, 2000
6. Mishra A, Friedman HS, Sinha AK: The effects of erythromycin on the electrocardiogram. Chest 115:983-986, 1999
7. Lee KL, Jim MH, Tang SC, et al: QT prolongation and torsades de pointes associated with clarithromycin. Am J Med 104:395-396, 1998
8. Ball P: Quinolone-induced QT interval prolongation: A not-so-unexpected class effect. J Antimicrob Chemother 45:557-559, 2000
9. Albengres E, Le Louet H, Tillement JP: Systemic antifungal agents. Drug interactions of clinical significance. Drug Saf 18:83-97, 1998
10. Ten Eick AP, Blumer JL, Reed MD: Safety of antihistamines in children. Drug Saf 24:119-147, 2001
11. Yap YG, Camm AJ: Arrhythmogenic mechanisms of non-sedating antihistamines. Clin Exp Allergy 29:174-181, 1999 (suppl 3)
12. Yap YG, Camm AJ: Risk of torsades de pointes with non-cardiac drugs. BMJ 320:1158-1159, 2000
13. Lindquist M, Edwards IR: Risk of non-sedating antihistamines. Lancet 349:1322, 1997
14. Parnes SM, Chuma AV: Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 79:18-20, 24-25, 2000
15. Tonini M, De Ponti F, Di Nucci A, et al: Review article: Cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13:1585-1591, 1999